Abstract Cannabis‐based medicinal products (CBMPs) are an emerging therapeutic option in the management of primary chronic pain, using the role…
Abstract Background: To date, no studies have directly assessed potential cannabis use disorder (CUD) in medical cannabis (MC) patients pre-…
Abstract In response to the need of more rigorous data on medical cannabis and chronic pain, we conducted a 3-month…
Abstract (1) Background: In November 2017, medical cannabis was legalized in Poland. Until now, there have been no studies conducted…
Abstract Background: Cannabis is increasingly used for therapeutic purpose. However, its safety profile is not well known. This study assessed…
Abstract Background: Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic…
Abstract Supplemental Digital Content is Available in the Text. Women are more susceptible to medical cannabis–related adverse effects because of…
Abstract Supplementary information: The online version contains supplementary material available at 10.1007/s00431-021-04202-z. Article type: Research Article Keywords: Medical cannabis, Cannabidiol,…
Abstract Background: The use of cannabis as medicine (CaM) both prescribed and non-prescribed has increased markedly in the last decade,…
Abstract Background: Globally, medical cannabis legalization has increased in recent years and medical cannabis is commonly used to treat chronic…